Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Fenchem Maintains Competitive Vitamin E price
The price of Fenchem’s TOCOVET® natural source vitamin E in North America is being maintained within the marketplace, due to large stocks and expanding production.
- Aquapharm and Croda International Sign Three Year Research Collaboration Agreement
Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
- Aquapharm and Croda International Sign Three Year Research Collaboration Agreement
Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
- Aquapharm and Croda International Sign Three Year Research Collaboration Agreement
Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
- Aquapharm and Croda International Sign Three Year Research Collaboration Agreement
Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care.
- DNP Notches 8% Second Quarter Increase
DNP International has reported an eight percent second quarter increase compared to last year during the same time.
- DNP Notches 8% Second Quarter Increase
DNP International has reported an eight percent second quarter increase compared to last year during the same time.
- Natural Alternatives International, Inc. Announces Sale of 'As We Change(R)' Assets and Provides Fourth Quarter Revenue Update
Natural Alternatives International, Inc. (NAII) has announced that it has sold the "As We Change(R)" catalog and internet business of Real Health Laboratories, Inc., its wholly owned subsidiary, for $2.0 million subject to certain adjustments.
- Natural Alternatives International, Inc. Announces Sale of 'As We Change(R)' Assets and Provides Fourth Quarter Revenue Update
Natural Alternatives International, Inc. (NAII) has announced that it has sold the "As We Change(R)" catalog and internet business of Real Health Laboratories, Inc., its wholly owned subsidiary, for $2.0 million subject to certain adjustments.
- Whole Foods Market reports third quarter results
Whole Foods Market, Inc. has announced FY Q3 results reporting sales of approximately $1.8 billion with comparable store sales increased 2.6% Net income was approximately $33.9 million, and diluted earnings per share were $0.24
- Whole Foods Market reports third quarter results
Whole Foods Market, Inc. has announced FY Q3 results reporting sales of approximately $1.8 billion with comparable store sales increased 2.6% Net income was approximately $33.9 million, and diluted earnings per share were $0.24
- Herbalife announces record Q2 results
Herbalife Ltd. (HLF) has announced FY08 Q2 results, reporting net sales of $639.7 million, an increase of 20.7 percent compared to the same period of 2007, with net income of $67.1 million, or $1.01 per diluted share, compared to $48.1 million, or $0.65 per diluted share in the second quarter of 2007.
- Herbalife announces record Q2 results
Herbalife Ltd. (HLF) has announced FY08 Q2 results, reporting net sales of $639.7 million, an increase of 20.7 percent compared to the same period of 2007, with net income of $67.1 million, or $1.01 per diluted share, compared to $48.1 million, or $0.65 per diluted share in the second quarter of 2007.
- Jamba, Inc. Announces Changes to Its Senior Management Team
Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen.
- Jamba, Inc. Announces Changes to Its Senior Management Team
Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen.
- Jamba, Inc. Announces Changes to Its Senior Management Team
Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen.
- Jamba, Inc. Announces Changes to Its Senior Management Team
Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen.
- General Nutrition Centers, Inc. Reports Second Quarter 2008 Financial Results
General Nutrition Centers, Inc. has announced FY08Q2 results, with reported revenues of $422.7 million, an 8.5% increase over the same quarter in 2007. This increase was the result of increased revenues in each of the Company's business segments: Retail by 6.3%; Franchise by 8.6%; and Manufacturing/Wholesale by 28.0%. Same store sales improved 4.5% in domestic company-owned stores (including internet sales), and 5.2% in Canadian stores
- General Nutrition Centers, Inc. Reports Second Quarter 2008 Financial Results
General Nutrition Centers, Inc. has announced FY08Q2 results, with reported revenues of $422.7 million, an 8.5% increase over the same quarter in 2007. This increase was the result of increased revenues in each of the Company's business segments: Retail by 6.3%; Franchise by 8.6%; and Manufacturing/Wholesale by 28.0%. Same store sales improved 4.5% in domestic company-owned stores (including internet sales), and 5.2% in Canadian stores
- Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility
Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA).
- Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility
Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA).
- Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility
Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA).
- Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility
Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA).
- Capsugel Obtains Australia’s TGA Certification For Its Licaps® Liquid-Fill Capsule Manufacturing Facility
Capsugel has announced that it has received certification from the Therapeutic Goods Administration (TGA) for its Licaps® liquid-fill capsule production facility in Greenwood, S.C. (USA).
- Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff
Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced.
- Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff
Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced.
- Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff
Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced.
- Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff
Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced.
- Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff
Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced.
- Sprunk-Jansen Launches Products Based On Greek-Arabic System, Opens US Office, Announces Staff
Sprunk-Jansen have announced the opening of their U.S. operation, along with a new sales team, Chief Operating Officer, President of U.S. operations and others involved in the company. Newly available products are also introduced.
- Senomyx Announces Second Quarter 2008 Financial Results
Senomyx has announced FY08Q2 results, reporting Q2 revenues of $9.6 million for the six months ended June 30, 2008, compared to $6.8 million for the six months ended June 30, 2007.
- Senomyx Announces Second Quarter 2008 Financial Results
Senomyx has announced FY08Q2 results, reporting Q2 revenues of $9.6 million for the six months ended June 30, 2008, compared to $6.8 million for the six months ended June 30, 2007.
- ChromaDex Completes $4.67 Million Capital Raise in Private Placement Transaction
ChromaDex Corporation has announced that on July 29, 2008, it completed its last round of sales under a private placement. The private placement, which was authorized for up to $6 million and has been on-going since March, yielded gross proceeds of approximately $4.67 million.
- ChromaDex Completes $4.67 Million Capital Raise in Private Placement Transaction
ChromaDex Corporation has announced that on July 29, 2008, it completed its last round of sales under a private placement. The private placement, which was authorized for up to $6 million and has been on-going since March, yielded gross proceeds of approximately $4.67 million.
- ChromaDex Completes $4.67 Million Capital Raise in Private Placement Transaction
ChromaDex Corporation has announced that on July 29, 2008, it completed its last round of sales under a private placement. The private placement, which was authorized for up to $6 million and has been on-going since March, yielded gross proceeds of approximately $4.67 million.
- NutraCea Announces Second Quarter 2008 Financial Results
NutraCea (NTRZ) has announced FY08 Q2 results, reporting net revenues of $10.3 million for the second quarter of 2008, compared to net revenues of $13.0 million for the second quarter of 2007, with a one-time license fee of $5.0 million (non-recurring) without which net revenues for the second quarter 2007 would have been $8,000,000. Net loss for the second quarter of 2008 was $6.1 million, or $(0.04) per share, compared to net income of $2.0 million or $0.01 per share for the same period last year.
- NutraCea Announces Second Quarter 2008 Financial Results
NutraCea (NTRZ) has announced FY08 Q2 results, reporting net revenues of $10.3 million for the second quarter of 2008, compared to net revenues of $13.0 million for the second quarter of 2007, with a one-time license fee of $5.0 million (non-recurring) without which net revenues for the second quarter 2007 would have been $8,000,000. Net loss for the second quarter of 2008 was $6.1 million, or $(0.04) per share, compared to net income of $2.0 million or $0.01 per share for the same period last year.
- KI NutriCare to Acquire Allergy Research Group for $1.33 Per Share in an All Cash Tender Offer Valued at Approximately $19,500,000
KI NutriCare, Inc. and Allergy Research Group, Inc. (ALRG) have announced that KI NutriCare, a wholly-owned subsidiary of Kikkoman Corporation (TSE:2801), Longhorn Acquisition Corp., a wholly-owned subsidiary of KI NutriCare formed to effect the transaction, and Allergy Research Group have entered into a definitive agreement pursuant to which Allergy Research Group will be acquired for approximately $19,500,000 through an all cash tender offer of $1.33 per share by Longhorn Acquisition Corp.
- KI NutriCare to Acquire Allergy Research Group for $1.33 Per Share in an All Cash Tender Offer Valued at Approximately $19,500,000
KI NutriCare, Inc. and Allergy Research Group, Inc. (ALRG) have announced that KI NutriCare, a wholly-owned subsidiary of Kikkoman Corporation (TSE:2801), Longhorn Acquisition Corp., a wholly-owned subsidiary of KI NutriCare formed to effect the transaction, and Allergy Research Group have entered into a definitive agreement pursuant to which Allergy Research Group will be acquired for approximately $19,500,000 through an all cash tender offer of $1.33 per share by Longhorn Acquisition Corp.
- Synutra Achieved 88.7% Net Sales Growth for the First Quarter Ended June 30, 2008
Company reports Q1 net sales in the first quarter ended June 30, 2008 increased by 88.7% to $127.4 million, compared to $67.5 million for the same quarter in 2007. First quarter net income increased by 193.0% to $15.6 million, compared to net income of $5.3 million in the same period in 2007. Synutra earned $0.29 per share (basic) in the first quarter of fiscal 2008, up 163.6% from $0.11 earned in the prior year period.
- Synutra Achieved 88.7% Net Sales Growth for the First Quarter Ended June 30, 2008
Company reports Q1 net sales in the first quarter ended June 30, 2008 increased by 88.7% to $127.4 million, compared to $67.5 million for the same quarter in 2007. First quarter net income increased by 193.0% to $15.6 million, compared to net income of $5.3 million in the same period in 2007. Synutra earned $0.29 per share (basic) in the first quarter of fiscal 2008, up 163.6% from $0.11 earned in the prior year period.
- Schiff Nutrition International, Inc. Announces Fiscal 2008 Fourth Quarter and Year-End Results
Schiff Nutrition International, Inc., has announced FY08 Q4 results reporting net sales were $50.4 million for the three months ended May 31, 2008, compared to $43.2 million for the same period in fiscal 2007. For the fiscal 2008 fourth quarter, Schiff Nutrition reported net income of $2.8 million, or $0.10 per diluted share, compared to net income of $3.7 million, or $0.13 per diluted share, for the same period a year ago. Schiff Nutrition's net sales were $176.9 million for the year ended May 31, 2008, compared to $172.7 million for fiscal 2007. For fiscal 2008, Schiff Nutrition reported net income of $11.3 million, or $0.40 per diluted share, compared to net income of $12.4 million, or $0.45 per diluted share, for fiscal 2007.
- Schiff Nutrition International, Inc. Announces Fiscal 2008 Fourth Quarter and Year-End Results
Schiff Nutrition International, Inc., has announced FY08 Q4 results reporting net sales were $50.4 million for the three months ended May 31, 2008, compared to $43.2 million for the same period in fiscal 2007. For the fiscal 2008 fourth quarter, Schiff Nutrition reported net income of $2.8 million, or $0.10 per diluted share, compared to net income of $3.7 million, or $0.13 per diluted share, for the same period a year ago. Schiff Nutrition's net sales were $176.9 million for the year ended May 31, 2008, compared to $172.7 million for fiscal 2007. For fiscal 2008, Schiff Nutrition reported net income of $11.3 million, or $0.40 per diluted share, compared to net income of $12.4 million, or $0.45 per diluted share, for fiscal 2007.
- Frutarom Second Quarter 2008 Results Release Scheduled for Tuesday, August 19, 2008
Frutarom announced that it will be releasing its second quarter 2008 results on Tuesday, August 19, 2008.
The Company will also be hosting a conference call on the same day at 2:00pm UK time or 9:00am EDT. During the call, management will review and discuss the results and will be available to answer investor questions.
- Frutarom Second Quarter 2008 Results Release Scheduled for Tuesday, August 19, 2008
Frutarom announced that it will be releasing its second quarter 2008 results on Tuesday, August 19, 2008.
The Company will also be hosting a conference call on the same day at 2:00pm UK time or 9:00am EDT. During the call, management will review and discuss the results and will be available to answer investor questions.
- Balchem Corporation's New Choline Memor-C Website Goes Live
Balchem Corporation today announced its Food, Pharma and Nutrition segment has launched a new website to provide information on its food grade Choline product line, Memor-C(tm), for food fortification.
- Balchem Corporation's New Choline Memor-C Website Goes Live
Balchem Corporation today announced its Food, Pharma and Nutrition segment has launched a new website to provide information on its food grade Choline product line, Memor-C(tm), for food fortification.
- Balchem Corporation's New Choline Memor-C Website Goes Live
Balchem Corporation today announced its Food, Pharma and Nutrition segment has launched a new website to provide information on its food grade Choline product line, Memor-C(tm), for food fortification.
- ISI Brands Teams With The Vitamin Shoppe to Debut Dr. Alan Greene Nutritional Supplement Line
ISI Brands, Inc./Twinlab(R) and renowned pediatrician Dr. Alan Greene have teamed with leading national health retailer The Vitamin Shoppe for the retail launch of Twinlab DrGreene(TM) line of nutritional supplements. The Vitamin Shoppe will debut the Dr. Greene nutritional supplement product line in mid-August, 2008 and will be celebrated with launch events in Vitamin Shoppe stores in San Francisco, New York, and Los Angeles.
- ISI Brands Teams With The Vitamin Shoppe to Debut Dr. Alan Greene Nutritional Supplement Line
ISI Brands, Inc./Twinlab(R) and renowned pediatrician Dr. Alan Greene have teamed with leading national health retailer The Vitamin Shoppe for the retail launch of Twinlab DrGreene(TM) line of nutritional supplements. The Vitamin Shoppe will debut the Dr. Greene nutritional supplement product line in mid-August, 2008 and will be celebrated with launch events in Vitamin Shoppe stores in San Francisco, New York, and Los Angeles.
- ISI Brands Teams With The Vitamin Shoppe to Debut Dr. Alan Greene Nutritional Supplement Line
ISI Brands, Inc./Twinlab(R) and renowned pediatrician Dr. Alan Greene have teamed with leading national health retailer The Vitamin Shoppe for the retail launch of Twinlab DrGreene(TM) line of nutritional supplements. The Vitamin Shoppe will debut the Dr. Greene nutritional supplement product line in mid-August, 2008 and will be celebrated with launch events in Vitamin Shoppe stores in San Francisco, New York, and Los Angeles.
- ISI Brands Teams With The Vitamin Shoppe to Debut Dr. Alan Greene Nutritional Supplement Line
ISI Brands, Inc./Twinlab(R) and renowned pediatrician Dr. Alan Greene have teamed with leading national health retailer The Vitamin Shoppe for the retail launch of Twinlab DrGreene(TM) line of nutritional supplements. The Vitamin Shoppe will debut the Dr. Greene nutritional supplement product line in mid-August, 2008 and will be celebrated with launch events in Vitamin Shoppe stores in San Francisco, New York, and Los Angeles.
- ISI Brands Teams With The Vitamin Shoppe to Debut Dr. Alan Greene Nutritional Supplement Line
ISI Brands, Inc./Twinlab(R) and renowned pediatrician Dr. Alan Greene have teamed with leading national health retailer The Vitamin Shoppe for the retail launch of Twinlab DrGreene(TM) line of nutritional supplements. The Vitamin Shoppe will debut the Dr. Greene nutritional supplement product line in mid-August, 2008 and will be celebrated with launch events in Vitamin Shoppe stores in San Francisco, New York, and Los Angeles.
- Forbes Medi-Tech Announces Second Quarter 2008 Financial Results
Forbes Medi-Tech Inc. today announced its results for the second quarter 2008 ended June 30, 2008. Comparative period for these statements is the three- and six-month periods ended June 30, 2007. Forbes reiterates its financial outlook for the full year 2008 and continues to expect sales of $9.75 million to $10.5 million, an increase of up to 18% compared to its reported revenues in 2007.
- Forbes Medi-Tech Announces Second Quarter 2008 Financial Results
Forbes Medi-Tech Inc. today announced its results for the second quarter 2008 ended June 30, 2008. Comparative period for these statements is the three- and six-month periods ended June 30, 2007. Forbes reiterates its financial outlook for the full year 2008 and continues to expect sales of $9.75 million to $10.5 million, an increase of up to 18% compared to its reported revenues in 2007.
- Galaxy Nutritional Foods Reports First Quarter Operating Results
Galaxy Nutritional Foods, Inc. has announced its FY08 Q1 results, reporting income from operations of $227,689 and net income of $119,951, or $0.01 per basic and diluted share, on net sales of approximately $6 million. In the prior-year quarter ended June 30, 2007, the Company reported net income of $150,999, or $0.01 per basic and diluted share, on net sales of approximately $5.9 million.
- Galaxy Nutritional Foods Reports First Quarter Operating Results
Galaxy Nutritional Foods, Inc. has announced its FY08 Q1 results, reporting income from operations of $227,689 and net income of $119,951, or $0.01 per basic and diluted share, on net sales of approximately $6 million. In the prior-year quarter ended June 30, 2007, the Company reported net income of $150,999, or $0.01 per basic and diluted share, on net sales of approximately $5.9 million.
- AIBMR Celebrates its 30th Anniversary
AIBMR Life Sciences, Inc. is celebrating its 30th year of service in the neutraceutical industry, servicing over 600 companies in the US and abroad.
- AIBMR Celebrates its 30th Anniversary
AIBMR Life Sciences, Inc. is celebrating its 30th year of service in the neutraceutical industry, servicing over 600 companies in the US and abroad.
- CV Technologies Reports Third Quarter Results
CV Technologies has released its FY08 Q3 results, reporting third quarter sales of $3.4 million, up 4.4% from sales of $3.2 million in the same quarter last year. The net loss was $2.0 million or $0.02 of net loss per share in the third quarter ended June 30, 2008, compared to a net loss of $1.9 million or $0.02 of net loss per share in the comparable period last year.
- CV Technologies Reports Third Quarter Results
CV Technologies has released its FY08 Q3 results, reporting third quarter sales of $3.4 million, up 4.4% from sales of $3.2 million in the same quarter last year. The net loss was $2.0 million or $0.02 of net loss per share in the third quarter ended June 30, 2008, compared to a net loss of $1.9 million or $0.02 of net loss per share in the comparable period last year.
- GLG Life Tech Corporation Announces Q2 2008 Results
GLG Life Tech Corporation has announced its FY08 Q2 results, reporting that revenues for the second quarter ending June 30, 2008 were $1,238,893, a decrease of 4.5% from $1,297,344 in revenue for the second quarter in 2007. Stevia revenue was $1,091,720 for the second quarter in 2008, a marginal decrease from $1,093,863 in the second quarter 2007.
- GLG Life Tech Corporation Announces Q2 2008 Results
GLG Life Tech Corporation has announced its FY08 Q2 results, reporting that revenues for the second quarter ending June 30, 2008 were $1,238,893, a decrease of 4.5% from $1,297,344 in revenue for the second quarter in 2007. Stevia revenue was $1,091,720 for the second quarter in 2008, a marginal decrease from $1,093,863 in the second quarter 2007.
- GLG Life Tech Corporation Announces Q2 2008 Results
GLG Life Tech Corporation has announced its FY08 Q2 results, reporting that revenues for the second quarter ending June 30, 2008 were $1,238,893, a decrease of 4.5% from $1,297,344 in revenue for the second quarter in 2007. Stevia revenue was $1,091,720 for the second quarter in 2008, a marginal decrease from $1,093,863 in the second quarter 2007.
- Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Tiens Biotech Group (USA), Inc., announced financial results for the second quarter and six months ended June 30, 2008. The company reports that for the second quarter ended June 30, 2008, revenue was $19.7 million, an increase of 37.2% compared to $14.3 million for the same period in 2007. Net income for the second quarter of 2008 was $4.6 million, compared to net income of $5.0 million for the second quarter of 2007. Earnings per share for the second quarter of each of 2008 and 2007 were $0.07. For the six months ended June 30, 2008, revenue was $32.5 million, an increase of 6.3% compared to $30.6 million for the same period in 2007.
- Tiens Biotech Group (USA) Reports Second Quarter and Six-Month Results
Tiens Biotech Group (USA), Inc., announced financial results for the second quarter and six months ended June 30, 2008. The company reports that for the second quarter ended June 30, 2008, revenue was $19.7 million, an increase of 37.2% compared to $14.3 million for the same period in 2007. Net income for the second quarter of 2008 was $4.6 million, compared to net income of $5.0 million for the second quarter of 2007. Earnings per share for the second quarter of each of 2008 and 2007 were $0.07. For the six months ended June 30, 2008, revenue was $32.5 million, an increase of 6.3% compared to $30.6 million for the same period in 2007.
- Lifeway Foods Reports Record Q2 and First Half 2008 Results
Lifeway Foods, Inc. has announced their FY08 Q2 results, reporting sales increased 19% to approximately $11,523,500 from $9,715,000 during the same period a year ago. Second quarter 2008 gross profit virtually unchanged to $3,872,569 from $3,829,076 during the same period a year ago. Gross margins were 34% in the second quarter 2008. Operating income was $1,546,161 for the second quarter 2008. Net Income was $911,718 for the second quarter 2008. Earnings per share were $.05 per share for the second quarter 2008.
- Lifeway Foods Reports Record Q2 and First Half 2008 Results
Lifeway Foods, Inc. has announced their FY08 Q2 results, reporting sales increased 19% to approximately $11,523,500 from $9,715,000 during the same period a year ago. Second quarter 2008 gross profit virtually unchanged to $3,872,569 from $3,829,076 during the same period a year ago. Gross margins were 34% in the second quarter 2008. Operating income was $1,546,161 for the second quarter 2008. Net Income was $911,718 for the second quarter 2008. Earnings per share were $.05 per share for the second quarter 2008.
- Fytokem announces reinstatement of trading on TSX Venture Exchange
Fytokem Products Inc. has announced that common shares in the capital of the Company will be reinstated for trading on the TSX Venture Exchange effective the opening Thursday, August 14, 2008.
- Fytokem announces reinstatement of trading on TSX Venture Exchange
Fytokem Products Inc. has announced that common shares in the capital of the Company will be reinstated for trading on the TSX Venture Exchange effective the opening Thursday, August 14, 2008.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Omega Protein Corporation, a leading producer of Omega-3 fish oil and specialty fish meal products, today reported net income of $6.7 million ($0.37 per share) for the second quarter of 2008, compared with net income of $2.5 million ($0.15 per share) for the second quarter of the previous year. Revenues for the second quarter ended June 30, 2008 were $47.1 million compared with revenues of $37.1 million for the comparable quarter in 2007. Omega Protein recorded operating income of $11.6 million for the 2008 second quarter, versus operating income of $5.1 million for the second quarter of 2007.
For the six months ended June 30, 2008, the Company had revenues of $83.2 million, compared with $68.2 million in revenues for the first six months of 2007. Omega Protein recorded operating income of $15.7 million for the six months ended June 30, 2008, versus operating income of $6.3 million for the comparable period a year earlier. The Company had net income of $8.6 million ($0.48 per share) for the six months ended June 30, 2008, compared with net income of $0.2 million ($0.01 per share) for the six months ended June 30, 2007.
Omega Protein's second quarter results reflect increased revenues and margins primarily due to higher volumes and sales prices from fish oil, partially offset by a decline in sales volume of fish meal. Average prices received for newly contracted fish oil sales, as compared to prices received during 2007, were approximately 63 percent higher and reflect increased demand from aquaculture and pet food manufacturers. Average prices for the Company's fish meal products were relatively flat between such periods. The results for the six months ended June 30, 2007 were impacted by the write-off of approximately $3.0 million in deferred debt issuance costs and prepayment fees resulting from the refinancing of the Company's prior credit agreement with a new credit facility in March 2007.
About Omega Protein
Omega Protein Corporation is the nation's largest manufacturer of heart-healthy fish oils containing Omega-3 fatty acids for human consumption, as well as specialty fish meals and fish oil used as value-added ingredients in aquaculture, swine and other livestock feeds. Omega Protein makes its products from menhaden, an Omega-3 rich fish that is not utilized as seafood, but which is abundantly available along the U.S. Gulf of Mexico and Atlantic Coasts.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS: The statements contained in this press release that are not historical facts are forward-looking statements that involve a number of risks and uncertainties. The actual results of future events described in any of these forward-looking statements could differ materially from those stated in the forward-looking statements. Important factors that could cause actual results to be materially different from those forward-looking statements include, among others: (1) the Company's ability to meet its raw material requirements through its annual menhaden harvest, which is subject to fluctuations due to natural conditions over which the Company has no control, such as varying fish population, fish oil yields, adverse weather conditions and disease; (2) the impact of worldwide supply and demand relationships on prices for the Company's products; (3) Omega Protein's expectations regarding demand for OmegaPure® proving to be incorrect; and (4) fluctuations in the Company's quarterly operating results due to the seasonality of the Company's business and its deferral of inventory sales based on worldwide prices for competing products. These and other factors are described in further detail in Omega's filings with the Securities and Exchange Commission, including its reports on Form 10-K, Form10-Q and Form 8-K. The Company also posts its latest internally generated price list for various products on its Company website, http://www.omegaproteininc.com. Pricing and product availability information disclosed in the price list are subject to change or discontinuance without prior notice, and the Company undertakes no obligation to update such information.
|